Industry News

Seven Cassidy-Led Bills Receive Hearing in Senate Health Committee, Added to PREVENT Pandemics Act

Posted on

WASHINGTON—Today, the U.S. Senate Health, Education, Labor, and Pension (HELP) Committee advanced the PREVENT Pandemics Act, which includes seven bills and additional provisions led by U.S. Senator Bill Cassidy, M.D. (R-LA). Dr. Cassidy’s bills prepare America to face future pandemics, by strengthening our Strategic National Stockpile, and increasing coordination between our public health infrastructure and health care system. The PREVENT Pandemics Act passed the HELP Committee 20-2 and…

Industry News

Generating real-world evidence at scale using advanced analytics

Posted on

Advanced techniques for generating real-world evidence (RWE) help pharmaceutical companies deliver insights that transform outcomes for patients—and create significant value. McKinsey estimates that over the next three to five years, an average top-20 pharma company could unlock more than $300 million a year by adopting advanced RWE analytics across its value chain. Opportunities…

AI, Collaborations, Competitor News

nference Accelerates Self-Supervised Language Model Training with Cerebras CS-2 System

Posted on

The ability to harness vast amounts of health data using advanced AI technology will lead to new discoveries and insights needed to improve patient care March 14, 2022 09:00 AM Eastern Daylight Time SUNNYVALE, Calif.–(BUSINESS WIRE)–Cerebras Systems, the pioneer in high performance artificial intelligence (AI) compute, and nference, an AI-driven health…

China, Collaborations, Competitor News, Data Partnership, International, Pharma

Hexvix® Has Obtained CDE Approval for the Inclusion In the Clinical Real-world Evidence Pilot Study

Posted on

SHANGHAI, March 14, 2022 /PRNewswire/ — Asieris Pharmaceuticals (688176.SH), a global innovative biopharma company specializing in discovering and developing innovative drugs for the treatment of genitourinary tumors and other major diseases, announced that the Hainan Provincial Medical Products Administration, in accordance with advice from the National Medical Products Administration Center for Drug Evaluation (CDE),…

Competitor News, M&A

Clarify Health Acquires Embedded Healthcare to Scale Value-Based Care for Health Plans

Posted on

Combined technologies strengthen Clarify’s leadership, creating the most comprehensive end-to-end value-based payments solution March 14, 2022 09:00 AM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Clarify Health, a leading cloud analytics and value-based payments platform company, announced today the acquisition of Embedded Healthcare, a behavior change platform company created by healthcare leaders…

Academic, AI, Collaborations, Competitor News

Exscientia and University of Oxford Launch “Xcellomics” Program to Expedite Early-Stage Academic Research and Translate Novel Biology Into Future Drug Discovery

Posted on

Program open at no-cost to any academic researcher interested in submitting a proposal March 10, 2022 08:00 AM Eastern Standard Time OXFORD, England–(BUSINESS WIRE)–Exscientia (Nasdaq: EXAI) and the University of Oxford Target Discovery Institute (Oxford TDI) today announced the formation of Xcellomics – a program designed to source cellular functional assays from the…

HR, Partner and Collaborator News

MITRE Appoints Dr. Stephen Ondra as New Chief Medical Advisor for Health and Human Services

Posted on

Newswise — McLean, Va., March 7, 2022— MITRE named Dr. Stephen Ondra as the new Chief Medical Advisor for MITRE’s work as operator of the CMS Alliance to Modernize Healthcare federally funded research and development center (Health FFRDC). The Health FFRDC is sponsored by the Centers for Medicare & Medicaid Services (CMS) and available…